Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia (Leukemia, (2021), 35, 9, (2698-2702), 10.1038/s41375-021-01273-7)

Inge van der Werf; Anna Wojtuszkiewicz; Huilan Yao; Rocco Sciarrillo; Manja Meggendorfer; Stephan Hutter; Wencke Walter; Jeroen Janssen; Wolfgang Kern; Claudia Haferlach; Torsten Haferlach; Gerrit Jansen; Gertjan J.L. Kaspers; Richard Groen; Gert Ossenkoppele; Jacqueline Cloos

doi:10.1038/s41375-021-01340-z

Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia (Leukemia, (2021), 35, 9, (2698-2702), 10.1038/s41375-021-01273-7)

Inge van der Werf, Anna Wojtuszkiewicz, Huilan Yao, Rocco Sciarrillo, Manja Meggendorfer, Stephan Hutter, Wencke Walter, Jeroen Janssen, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach, Gerrit Jansen, Gertjan J.L. Kaspers, Richard Groen, Gert Ossenkoppele, Jacqueline Cloos

Research related

Onderzoeksoutput: Bijdrage aan tijdschrift › Opmerking/debat

Samenvatting

Despite carefully proofreading our submission, we missed a mistake in the affiliation of Wolfgang Kern, Claudia Haferlach and Torsten Haferlach. Instead of (2) H3 Biomedicine, their affiliation should be (3) MLL Munich Leukemia Laboratory, Munich, Germany.

Originele taal-2	Engels
Pagina's (van-tot)	2735
Aantal pagina's	1
Tijdschrift	Leukemia
Volume	35
Nummer van het tijdschrift	9
DOI's	https://doi.org/10.1038/s41375-021-01340-z
Status	Gepubliceerd - sep. 2021

Toegang tot document

10.1038/s41375-021-01340-z

Citeer dit

van der Werf, I., Wojtuszkiewicz, A., Yao, H., Sciarrillo, R., Meggendorfer, M., Hutter, S., Walter, W., Janssen, J., Kern, W., Haferlach, C., Haferlach, T., Jansen, G., Kaspers, G. J. L., Groen, R., Ossenkoppele, G., & Cloos, J. (2021). Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia (Leukemia, (2021), 35, 9, (2698-2702), 10.1038/s41375-021-01273-7). Leukemia, 35(9), 2735. https://doi.org/10.1038/s41375-021-01340-z

@article{52474c051f3640ee9a921e765bdf9da8,

title = "Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia (Leukemia, (2021), 35, 9, (2698-2702), 10.1038/s41375-021-01273-7)",

abstract = "Despite carefully proofreading our submission, we missed a mistake in the affiliation of Wolfgang Kern, Claudia Haferlach and Torsten Haferlach. Instead of (2) H3 Biomedicine, their affiliation should be (3) MLL Munich Leukemia Laboratory, Munich, Germany.",

author = "{van der Werf}, Inge and Anna Wojtuszkiewicz and Huilan Yao and Rocco Sciarrillo and Manja Meggendorfer and Stephan Hutter and Wencke Walter and Jeroen Janssen and Wolfgang Kern and Claudia Haferlach and Torsten Haferlach and Gerrit Jansen and Kaspers, {Gertjan J.L.} and Richard Groen and Gert Ossenkoppele and Jacqueline Cloos",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s), under exclusive licence to Springer Nature Limited.",

year = "2021",

month = sep,

doi = "10.1038/s41375-021-01340-z",

language = "English",

volume = "35",

pages = "2735",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "9",

}

van der Werf, I, Wojtuszkiewicz, A, Yao, H, Sciarrillo, R, Meggendorfer, M, Hutter, S, Walter, W, Janssen, J, Kern, W, Haferlach, C, Haferlach, T, Jansen, G, Kaspers, GJL, Groen, R, Ossenkoppele, G & Cloos, J 2021, 'Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia (Leukemia, (2021), 35, 9, (2698-2702), 10.1038/s41375-021-01273-7)', Leukemia, vol. 35, nr. 9, blz. 2735. https://doi.org/10.1038/s41375-021-01340-z

TY - JOUR

T1 - Author Correction

T2 - SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia (Leukemia, (2021), 35, 9, (2698-2702), 10.1038/s41375-021-01273-7)

AU - van der Werf, Inge

AU - Wojtuszkiewicz, Anna

AU - Yao, Huilan

AU - Sciarrillo, Rocco

AU - Meggendorfer, Manja

AU - Hutter, Stephan

AU - Walter, Wencke

AU - Janssen, Jeroen

AU - Kern, Wolfgang

AU - Haferlach, Claudia

AU - Haferlach, Torsten

AU - Jansen, Gerrit

AU - Kaspers, Gertjan J.L.

AU - Groen, Richard

AU - Ossenkoppele, Gert

AU - Cloos, Jacqueline

PY - 2021/9

Y1 - 2021/9

N2 - Despite carefully proofreading our submission, we missed a mistake in the affiliation of Wolfgang Kern, Claudia Haferlach and Torsten Haferlach. Instead of (2) H3 Biomedicine, their affiliation should be (3) MLL Munich Leukemia Laboratory, Munich, Germany.

AB - Despite carefully proofreading our submission, we missed a mistake in the affiliation of Wolfgang Kern, Claudia Haferlach and Torsten Haferlach. Instead of (2) H3 Biomedicine, their affiliation should be (3) MLL Munich Leukemia Laboratory, Munich, Germany.

UR - http://www.scopus.com/inward/record.url?scp=85109800171&partnerID=8YFLogxK

U2 - 10.1038/s41375-021-01340-z

DO - 10.1038/s41375-021-01340-z

M3 - Comment/debate

C2 - 34272482

AN - SCOPUS:85109800171

SN - 0887-6924

VL - 35

SP - 2735

JO - Leukemia

JF - Leukemia

IS - 9

ER -

Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia (Leukemia, (2021), 35, 9, (2698-2702), 10.1038/s41375-021-01273-7)

Samenvatting

Toegang tot document

Vingerafdruk

Citeer dit